CIK 0000070487
- Accelerated filer
NRC HEALTH
Sign in to watch- Ticker
- NRC
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 470634000
- Phone
- +1 402-475-2525
- Business address
- 1245 Q STREET, LINCOLN, NE, 68508
- Former names
- NATIONAL RESEARCH CORP
- 4 Grant or award 10% owner acquired 1,884,205 shares (grant or award)
- 4 Grant or award Director acquired 23,194 shares (grant or award)
- 4 Grant or award Director acquired 6,902 shares (grant or award)
- 4 Grant or award Director acquired 43,179 shares (grant or award)
- 4 Grant or award Director acquired 5,090 shares (grant or award)
- 4 Shares withheld for taxes SVP Finance, CFO, Treas & Secy gave up 3,436 shares (to pay taxes)
- 4 Shares withheld for taxes President gave up 4,991 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 1,799 shares (to pay taxes)
- 4 Open-market sale Director sold 3,000 shares at $28.75 ($86,250)
- 4 Open-market sale Director sold 100 shares at $29.50 ($2,950)
- 4 Open-market sale Director sold 4,068 shares at $28.87 ($117,441)
- 4 Open-market sale Director sold 4,991 shares at an average $28.66 ($143,043)
- 4 Open-market sale Director sold 356 shares at an average $30.15 ($10,732)
- 4 Open-market sale Director sold 5,612 shares at an average $31.13 ($174,717)
- 4 Open-market sale Director sold 2,383 shares at $31.74 ($75,642)
- 4/A Shares withheld for taxes President gave up 38,502 shares (to pay taxes)
- 4 Open-market sale CEO sold 5,261,410 shares at $19.31 ($101,597,827)
- 4 Open-market buy 10% owner bought 5,494,440 shares at $19.31 ($106,097,636)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CEO sold 1,602,399 shares at $39.03 ($62,541,633)
Page 16 of 40 · 787 filings